Form 8.3

Rathbones Group plc filed a Rule 8.3 disclosure for Advanced Medical Solutions Group plc showing an opening position of 13,746,653 shares of 5p Ordinary Shares (6.23%). The filing also reports multiple sales of 5p Ordinary Shares at ~279.25p–279.67p per unit (e.g., 25,000; 14,340; 7,870; 50,000 shares). No supplemental open-positions form was attached and no other parties to the offer were disclosed.

Analysis

This reads as register housekeeping, not a new fundamental signal. The only market-relevant takeaway is that a meaningful holder is still active around a live corporate event, which can keep the name in the event-driven bucket and sustain a small liquidity/borrow overhang even if the economics of the business have not changed.

The second-order effect is on price discovery, not valuation: when a holder above the disclosure threshold trims into an offer process, it often signals that the free float is being redistributed rather than that a thesis has broken. For a target like AMS, that typically tightens the trading range around whatever the market believes the transaction value is, while making incremental upside increasingly dependent on a formal bid revision or competing interest rather than organic fundamentals.

Contrarian read: this is not evidence of informed selling unless we see a pattern of larger reductions, derivatives activity, or parallel changes from other holders. The main falsifier for any event-driven bullish read is a widening gap between the traded price and implied deal value over the next 1-4 weeks, especially if other institutional disclosures show net distribution rather than accumulation. Absent that, the right stance is patience rather than urgency.

Key Decisions for Investors

• No new outright position on RTBBF/AMS from this filing alone; treat as low-signal flow unless a larger holder follows with a materially bigger reduction within 5-10 trading days.
• If already in an event-driven long, hold only against a clearly defined deal-value anchor; trim 25-50% if the stock trades to within ~1-2% of implied value and there is no confirmation of competing interest.
• Watch for the next 8.3/8.5 disclosures and any offer timetable updates; a cluster of passive-holder sells would be the first actionable sign that supply is coming before the catalyst resolves.
• For arb desks, consider a very small, optionality-style long only if the discount to implied value persists after this filing; otherwise avoid forcing a pair trade without confirmed offer terms.
• Set an alert on a break below the recent event-driven trading range; that would suggest the market is reading the disclosure as distribution rather than routine compliance, which would weaken the bid-support thesis.